FindTrial
Sign In

The current status and influencing factors of mental resilience in prostate cancer patients undergoing androgen deprivation therapy

The current status and influencing factors of mental resilience in prostate cancer patients undergoing androgen deprivation therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043647
Enrollment
Unknown
Registered
2021-02-24
Start date
2021-02-17
Completion date
Unknown
Last updated
2021-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

case series:Nil

Sponsors

Nantong University School of Medicine (School of Nursing)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients with clinicopathologically diagnosed prostate cancer; 2. Patients receiving androgen deprivation therapy; 3. Conscious patients who can fill in questionnaires independently or with the help of investigators; 4. Patients know the truth about their condition.

Exclusion criteria

Exclusion criteria: 1. Patients who refused to accept the investigation; 2. The patient cannot be investigated due to physical, psychological and mental reasons, such as unstable condition, combined with serious organic disease, cognitive impairment, etc.; 3. Patients who only know part of the disease.

Design outcomes

Primary

MeasureTime frame
Connor-Davidson Resilience Scale, CD-RISC;The Aging Males' Symptoms Scale, AMS;—

Countries

China

Contacts

Public ContactZhang Lan-Feng

The First Affiliated Hospital of Soochow University

gjyang@suda.edu.cn+86 13862953229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026